Skip to main content

Advertisement

SpringerLink
Log in

Familial Follicular Cell Tumors: Classification and Morphological Characteristics

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Familial follicular cell-derived well-differentiated thyroid cancer, papillary (PTC), and follicular thyroid carcinomas (FTC), accounts for 95% of thyroid malignancies. The majority of are sporadic, and at least 5% of these patients will have familial disease. Familial thyroid syndromes are classified into familial medullary thyroid carcinoma (FMTC), derived from calcitonin-producing C cells, and familial follicular cell tumors or non-medullary thyroid carcinoma (FNMTC), derived from follicular cells. Twenty-five percent of patients with medullary thyroid cancer (MTC) have a familial form; however, this accounts for only 1% of all patients with thyroid cancer. The familial follicular cell-derived lesions or familial non-medullary thyroid cancer can be divided into two clinical–pathological groups. The first group includes familial syndromes characterized by a predominance of non-thyroidal tumors, such as familial adenomatous polyposis (FAP), PTEN-hamartoma tumor syndrome (Cowden disease; PHTS), Carney complex, Werner syndrome, and Pendred syndrome. The second group includes familial syndromes characterized by predominance of papillary thyroid carcinoma (PTC), such as pure fPTC, fPTC associated with papillary renal cell carcinoma, and fPTC with multinodular goiter. Most of the progress in the genetics of familial thyroid cancer has been in patients with MTC. This is usually a component of multiple endocrine neoplasias IIA or IIB, or as pure familial medullary thyroid carcinoma syndrome. The genetic events in the familial C-cell-derived tumors are known and genotype–phenotype correlations are well established. The mutations in patients with isolated NMFTC have not been as well defined as in MTC. In many cases, patients have a known familial syndrome that has defined risk for thyroid cancer. The clinician must be knowledgeable in recognizing the possibility of an underlying familial syndrome when a patient presents with thyroid cancer. Some characteristic thyroid morphologic findings should alert the pathologist of a possible familial cancer syndrome, which may lead to further molecular genetics evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. American Cancer Society 2007 Cancer Facts and Figures 2007. American Cancer Society, Atlanta, GA.

    Google Scholar 

  2. Horner MJ, Ries L, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse S, Feuer E, Huang L, Mariotto A, Miller B, Lewis D, Eisner M, Stinchcomb D, Edwards B (eds) 2009 SEER Cancer Statistics Review, 1975–2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site.

  3. Nosé V. Familial Non-medullary thyroid carcinoma: an update. Endocr Pathol 2008; 19:226–240.

    Article  PubMed  Google Scholar 

  4. Dotto J, Nosé V. Familial thyroid carcinoma: a diagnostic algorithm. Adv Anat Pathol 2008;15:332-349.

    Article  PubMed  Google Scholar 

  5. Harach HR, Soubeyran I, Brown A, et al. Thyroid pathologic findings in patiients with Cowden disease. Ann Diagnost Pathol 1999;3:331-340.

    Article  CAS  Google Scholar 

  6. Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgins L. The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet. 2001;38(1):52-58.

    Article  CAS  PubMed  Google Scholar 

  7. Zambrano E, Holm I, Glickman J, et al. Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated diseases. Endoc Pathol 2004; 15:1;55-64

    Article  Google Scholar 

  8. Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 1994, 25:549–561.

    Article  CAS  PubMed  Google Scholar 

  9. Soravia C, Sugg SL, Berk T, et al. Familial adenomatous polyposis-associated thyroid cancer: a clinical pathological, and molecular genetics study. Am J Pathol 1999, 154:127-135

    CAS  PubMed  Google Scholar 

  10. Cameselle-Teijeiro J, Chan JK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 1999;12(4):400-411.

    CAS  PubMed  Google Scholar 

  11. Cetta F, Montalto G, Gori M, Curia M, Cama A, Olschwang S Germline mutations of the APC gene in patients with FAP associated thyroid carcinoma. Results from a European cooperative study. J Clin Endocrinol Metab 2000; 85:286–292.

    Article  CAS  PubMed  Google Scholar 

  12. Stratakis C, Courcoutsakis N, Abati A, Filie A, Doppman J, Carney J, Shawker T Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 1997; 82:2037–2043.

    Article  CAS  PubMed  Google Scholar 

  13. Matyakhina L, Pack S, Kirschner L, Pak E, Mannan P, Jaikumar J, Taymans S, Sandrini F, Carney J, Stratakis C Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 2003; 40:268–277.

    Article  CAS  PubMed  Google Scholar 

  14. Nehlin J, Skovgaard G, Bohr V The Werner syndrome. A model for the study of human aging. Ann NY Acad Sci 2000; 908:167–179.

    Article  CAS  PubMed  Google Scholar 

  15. Muftuoglu M, Oshima J, von Kobbe C, Cheng W, Leistritz D, Bohr V The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis. Hum Genet 2008; 124:369–377.

    Article  CAS  PubMed  Google Scholar 

  16. Ishikawa Y, Sugano H, Matsumoto T, Furuichi Y, Miller R, Goto M Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer Sci 1999; 85:1345–1352.

    CAS  Google Scholar 

  17. Reardon W, Coffey R, Phelps P, Luxon L, Stephens D, Kendall-Taylor P, Britton K, Grossman A, Trembath R Pendred syndrome-100 years of underascertainment? QJM; 1997 90:443–447.

    Article  CAS  PubMed  Google Scholar 

  18. Snabboon T, Plengpanich W, Saengpanich S, Sirisalipoch S, Keelawat S, Sunthornyothin S, Khovidhunkit W, Suwanwalaikorn S, Sridama V, Shotelersuk V Two common and three novel PDS mutations in Thai patients with Pendred syndrome. J Endocrinol Invest 2007; 30:907–913.

    CAS  PubMed  Google Scholar 

  19. Malchoff CD, Sarfarazi M, Tendler B, et al. Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli. Thyroid 1999, 9:247–252.

    Article  CAS  PubMed  Google Scholar 

  20. Takami H, Ozaki O, Ito K. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Arch Surg 1996;131:676.

    CAS  PubMed  Google Scholar 

  21. Triponez F, Wong M, Sturgeon C, et al. Does familial nonmedullary thyroid cancer adversely affect survival? World J Surg 2006;30:787–793

    Article  PubMed  Google Scholar 

  22. Bakhsh A, Kirov G, Gregory GW, et al. A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. Endocrine-Related Cancer 2006, 13: 475-483

    Article  CAS  PubMed  Google Scholar 

  23. McKay JD, Lesueur F, Jonard L, et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001; 69:440–446.

    Article  CAS  PubMed  Google Scholar 

  24. Malchoff CD, Sarfarazi M, Tendler B, et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000;85:1758–1764

    Article  CAS  PubMed  Google Scholar 

  25. Burgess JR, Duffield A, Wilkinson SJ, et al. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 1997, 82:345–348.

    Article  CAS  PubMed  Google Scholar 

  26. Lesueur F, Stark M, Tocco T, et al. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 1999, 84:2157–2162

    Article  CAS  PubMed  Google Scholar 

  27. Canzian F, Amati P, Harach HR, et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998, 63:1743–1748

    Article  CAS  PubMed  Google Scholar 

  28. Uchino S, Noguchi S, Kawamoto H, et al. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 2002;26:897–902.

    Article  PubMed  Google Scholar 

  29. Alsanea O, Wada N, Ain K, et al. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 2000;128:1043–1050, discussion 1050–1051.

    Article  CAS  PubMed  Google Scholar 

  30. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 1995; 130:892–897.

    CAS  PubMed  Google Scholar 

  31. Nosé V. Familial Thyroid Cancer: A Review. 2010. Modern Pathology (in press).

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Miami School of Medicine, 1120 NW 14th Avenue, Miami, FL, 33136, USA

    Vânia Nosé

Authors
  1. Vânia Nosé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vânia Nosé.

Additional information

Presented in part at the USCAP Endocrine Pathology Companion Meeting, Washington, DC, March 2010

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nosé, V. Familial Follicular Cell Tumors: Classification and Morphological Characteristics. Endocr Pathol 21, 219–226 (2010). https://doi.org/10.1007/s12022-010-9135-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-010-9135-6

Keywords

Search

Navigation